← Back to Search

Transportation Assistance for Liver Transplant Patients (TAP-LT Trial)

N/A
Waitlist Available
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Deemed ineligible for liver transplantation during initial evaluation visit
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether using rideshares can help people get to their transplant-related medical appointments.

Who is the study for?
This trial is for adults over 18 who have attended an initial liver transplant clinic visit. It's not open to pregnant women, prisoners, those ineligible for a transplant after the first evaluation, or without a Phase 2 referral. Participants must live within 60 miles of Keck Hospital and be able to consent.
What is being tested?
The study is testing if providing Lyft rides helps patients attend medical appointments related to liver transplants more reliably. This includes visits with doctors, lab tests, and imaging needed before being put on the waitlist for a transplant.
What are the potential side effects?
Since this trial offers transportation assistance rather than medication, there are no direct medical side effects. However, participants may experience issues like delays or discomfort associated with using the provided transportation service.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was told I can't have a liver transplant after my first check-up.
Select...
I am unable to understand or sign the consent form.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time to waitlisting for liver transplant
Secondary study objectives
Number of hospitalizations
Number of no-shows/cancellations
Patient satisfaction with care
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Transportation assistance, reports unreliable transportationExperimental Treatment1 Intervention
Lyft rides provided to transplant-related appointments
Group II: Transportation assistance, controlActive Control1 Intervention
No intervention, standard-of-care
Group III: No transportation assistance, reports unreliable transportationActive Control1 Intervention
No intervention, standard-of-care

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
944 Previous Clinical Trials
1,604,585 Total Patients Enrolled

Media Library

Transportation assistance (Lyft rides) Clinical Trial Eligibility Overview. Trial Name: NCT05080595 — N/A
Liver Transplant Research Study Groups: Transportation assistance, control, Transportation assistance, reports unreliable transportation, No transportation assistance, reports unreliable transportation
Liver Transplant Clinical Trial 2023: Transportation assistance (Lyft rides) Highlights & Side Effects. Trial Name: NCT05080595 — N/A
Transportation assistance (Lyft rides) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05080595 — N/A
~16 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top